Meniscus Repair Systems - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

The meniscus repair systems market size is projected to expand from USD 0.7 billion in 2025 and USD 0.79 billion in 2026 to USD 1.49 billion by 2031, registering a CAGR of 13.49% between 2026 to 2031. This report is Segmented by Procedure Technique (All-Inside, Inside-Out, Outside-In, Meniscal Root Repair, Hybrid/Augmented Repairs), End User (Hospitals, Ambulatory Surgical Centers (ASCs), and Specialty Orthopedic Clinics), Tear Type (Radial, Vertical Longitudinal, Horizontal Cleavage, and More), and Geography (North America, Europe, and More). Market Forecasts are Provided in Terms of Value (USD).

Global Meniscus Repair Systems Market Trends and Insights

Shift From Meniscectomy to Repair to Reduce OA Progression and Preserve Function

A 2024 meta-analysis found that meniscal repair reduced the 10-year incidence of radiographic osteoarthritis by 51% compared with partial meniscectomy . The data spurred orthopedic societies in North America and Europe to update their guidelines in favor of repair. Payers are realigning reimbursement, and bundled payment models are rewarding centers that opt for preservation. As value-based contracts proliferate, surgeons are increasingly repairing tears once considered marginal, propelling the meniscus repair systems market.

All-Inside and Knotless All-Suture Systems Enable Broader Tear Indications

Biomechanical studies show that knotless all-suture repairs achieve 98.6% deployment success with only 6.35% failure rates across diverse tears . FDA clearances for Arthrex FiberTak (March 2025) and GMReis MENISCUS VERSAFLEX (February 2026) cement regulatory confidence. The simplified workflow - fewer portals, no risk of hardware removal, and shorter operative time - has widened indications to include complex, radial, and horizontal cleavage tears, expanding the meniscus repair systems market.

Cost Pressure From GPOs, Procurement, and Bundling with Towers/Instruments

GPOs now influence more than USD 250 billion in U.S. hospital spending and negotiate double-digit discounts by bundling repair devices with arthroscopy towers. Mid-tier suppliers with narrow portfolios face margin compression or exclusion from formularies. ASCs, operating on lean budgets, prefer single-use kits that minimize reprocessing costs but increase manufacturing costs. These dynamics temper near-term pricing power in the meniscus repair systems market.

Other drivers and restraints analyzed in the detailed report include:

• Increasing Arthroscopy Volumes and Sports Injury Incidence
• Outpatient/ASC Adoption Accelerating Knee Arthroscopy Throughput
• Long-Term Repair Failure/Rehab Burden in Complex/Degenerative Tears

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

All-inside systems dominated segment revenue with 38.30% of the meniscus repair systems market size in 2025 and are growing at a 15.40% CAGR. Knotless all-suture constructs eliminate hardware complications and require only standard anteromedial and anterolateral portals, reducing operative time. Inside-out methods retain a niche among academic surgeons citing marginally higher ultimate load-to-failure values, yet share is eroding as cadaveric data show biomechanical parity. Outside-in techniques, once preferred for anterior horn tears, are losing traction because all-inside devices can treat the same pathology through fewer incisions. Root repair, a subset tracked separately, is the fastest-advancing micro-segment; dedicated pull-out systems cleared in 2024-2025 have made fixation reproducible. Hybrid repairs that pair sutures with compression implants or biologic scaffolds are entering early adoption, targeting revision or poor-quality tissue cases and adding premium price layers to the meniscus repair systems market.

Market adoption is reinforced by surgeon education, virtual-reality simulation, and design enhancements such as self-punching tips that remove pre-drilling steps. Manufacturers are packaging implants in sterile, single-use trays aligned with ASC workflows. The interplay of reliability, shorter learning curves, and throughput gains keeps all-inside devices at the center of capital planning for hospitals and surgery centers alike, securing their lead within the meniscus repair systems market.

Complete Report Scope:

• By Procedure Technique
  • All-inside
  • Inside-out
  • Outside-in
  • Meniscal root repair
  • Hybrid/augmented repairs
• By End User
  • Hospitals
  • Ambulatory Surgical Centers (ASCs)
  • Specialty Orthopedic Clinics
• By Tear Type
  • Radial
  • Vertical longitudinal
  • Horizontal cleavage
  • Complex / bucket-handle
  • Root tears
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa
    • GCC
    • South Africa
    • Rest of Middle East and Africa
  • South America
    • Brazil
    • Argentina
    • Rest of South America

Geography Analysis

North America commanded 42.13% of the meniscus repair systems market in 2025, driven by high arthroscopy penetration, broad sports participation, and the world's fastest regulatory cycle. The FDA cleared multiple next-generation systems in 2025-2026, giving regional surgeons early access to knotless and root-specific technologies. ASC migration is well advanced; payers favor lower-cost settings and bundled payments, a structural driver that continues to lift procedure volumes and sustain premium pricing for pre-loaded kits.

Europe’s growth is steadied by robust surgeon training networks and universal coverage, but faces friction from Medical Device Regulation timelines averaging 2.5 years . Device withdrawals due to certification backlog create intermittent supply gaps that favor incumbents with deep regulatory resources. Nonetheless, Germany, the United Kingdom, and France remain high-value markets where well-maintained registries furnish long-term data supporting repair, anchoring demand even as pricing pressure from centralized tenders intensifies.

Asia-Pacific is the fastest-growing region, posting a projected 15.12% CAGR. China streamlined Class III orthopedic approvals, encouraging both multinationals and local firms to launch cost-matched versions of all-inside platforms. India benefits from rising insurance coverage and government investment in tier-2 city surgical infrastructure. Japan and South Korea, already saturated with advanced arthroscopy capacity, are early adopters of root-specific and hybrid repairs, while Australia’s sports culture sustains steady volume. Middle East & Africa and South America remain nascent but gain traction as private hospitals in the Gulf Cooperation Council, Brazil, and Argentina install modern arthroscopy suites.

List of Companies Covered in this Report:

• Arcuro Medical
• Arthrex
• Auxein Medical
• Biotek SRL
• Changzhou Toolmed Medical Instrument
• Conmed
• Double Medical Technology
• Healthium Medtech
• Johnson & Johnson
• Karl Storz
• Medacta International SA
• Native Orthopaedics
• Orthovasive
• Sironix
• Smiths Group
• Stryker
• VIMS System
• Zimmer Biomet

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support